Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07678060 · ClinicalTrials.gov registry record · NA
Targeting Fronto-Striatal Neural Circuitry Using Repetitive Transcranial Magnetic Stimulation to Reduce Irritability
A NA study, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07678060 is a NA study that is active but no longer recruiting, run by Yale University. The registered enrollment target is 20 participants.
The verdict
NCT07678060, a NA study, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilor study will use repetitive Transcranial Magnetic Stimulation (rTMS) as a noninvasive circuit-based neural modulation to test frontostriatal circuitry as a potential target to reduce irritability.
Interventions
- DEVICE repetitive transcranial magnetic stimulation (rTMS)
- DIAGNOSTIC_TEST fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07678060
The ClinicalTrials.gov registry entry for NCT07678060 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT07678060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07678060 about?
NCT07678060 is a clinical study titled "Targeting Fronto-Striatal Neural Circuitry Using Repetitive Transcranial Magnetic Stimulation to Reduce Irritability". This pilor study will use repetitive Transcranial Magnetic Stimulation (rTMS) as a noninvasive circuit-based neural modulation to test frontostriatal circuitry as a potential target to reduce irritability.
What is the current status of trial NCT07678060?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-09-01. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07678060?
The interventions under investigation include: repetitive transcranial magnetic stimulation (rTMS) (DEVICE), fMRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07678060?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.